JCO-ovid
Indian Journal of Cancer
Home  ICS  Feedback Subscribe Top cited articles Login 
Users Online :616
Small font sizeDefault font sizeIncrease font size
Read this article

 


    Article Cited by others

ORIGINAL ARTICLE

Everolimus plus octreotide long-acting repeatable in advanced neuroendocrine tumors in the routine tertiary cancer care setting: An Indian experience

Tippeswamy R, Patil S, Sateesh C T, Shashidhara H P, Prabhudesai S, Prashanth P, Haridas K M

Year : 2015| Volume: 52| Issue : 3 | Page no: 359-362

   This article has been cited by
 
1 Everolimus as first line therapy for pancreatic neuroendocrine tumours: current knowledge and future perspectives
Marco Gallo,Pasqualino Malandrino,Giuseppe Fanciulli,Francesca Rota,Antongiulio Faggiano,Annamaria Colao
Journal of Cancer Research and Clinical Oncology. 2017; 143(7): 1209
[Pubmed]  [Google Scholar] [DOI]

 

  Site Map | What's new | Copyright and Disclaimer
  Online since 1st April '07
  2007 - Indian Journal of Cancer | Published by Wolters Kluwer - Medknow